JPRN-UMIN000011191
Completed
未知
Efficacy and tolerability of escitalopram versus paroxetine-CR in Japanese patients with major depressive disorder: a randomized, masked-rater trial - A randomized controlled trial of escitalopram versus paroxetine-CR in major depressive disorder
Department of Psychiatry, Fujita Health University School of Medicine0 sites200 target enrollmentJuly 16, 2013
Conditionsmajor depressive disorder
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- major depressive disorder
- Sponsor
- Department of Psychiatry, Fujita Health University School of Medicine
- Enrollment
- 200
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patient with the following disorders (based on DSM\-IV\-TR criteria): psychotic disorders, pervasive developmental disorders, bipolar disorder, obsessive\-compulsive disorder, Axis\-2 disorder. Patients with substance abuse or dependence (excluding nicotine and caffeine) meeting DSM\-IV\-TR criteria Patients taking MAO inhibitors with in14 days (or Patients treated with MAO inhibitors within 14 days) Patients taking pimozide Patients with allergies to escitalopram, citalopram and paroxetine Patients with QT interval prolongation Patients treated with ECT within the previous 6 months Patients having severe physical disease Patients who are pregnant or may become pregnant Patients at significant risk of suicide (having a score \>3 on HAM\-D item 11\) Patients who had made suicide attempt within the past year
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Treatment of depressive symptoms in patients with heart failureDepression.Major depressive disorder, single episode, mildF32.0IRCT20190525043700N5Babol University of Medical Sciences80
Completed
Phase 2
Evaluation of the effect of Escitalopram versus placebo trial on changing the neuroticismeuroticism or neuroticism.Post-traumatic stress disorder, acuteF43.11IRCT20211208053331N1Ahvaz University of Medical Sciences172
Recruiting
Not Applicable
escitalopram in depressive patients with acute coronary artery syndromeMental and behavioral disordersKCT0000053Chonnam National University Hospital300
Completed
Phase 4
Comparison Of Two Anti Depressant Drugs In Major Depressive DisorderHealth Condition 1: null- Major Depressive DisorderCTRI/2018/02/011662Government Medical College50
Recruiting
Phase 2
Efficacy of Escitalopram, Venlafaxine and Buspirone in Irritable Bowel SyndromeIrritable bowel syndrome.Irritable bowel syndromeIRCT20150630022991N10Babol University of Medical Sciences90